recurrent prostate cancer

Showing 51 - 75 of 92

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Prostate Cancer, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Los Angeles (laboratory biomarker

Completed
  • Prostate Cancer
  • +3 more
  • laboratory biomarker analysis
  • +2 more
  • Los Angeles, California
    University of Southern California
Jul 5, 2017

Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer, Stage IV Prostate Cancer Trial in Los Angeles (abiraterone

Unknown status
  • Hormone-resistant Prostate Cancer
  • +2 more
  • abiraterone acetate
  • +2 more
  • Los Angeles, California
    USC Norris Comprehensive Cancer Center
Jul 5, 2017

Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Portland (drug, dietary

Terminated
  • Adenocarcinoma of the Prostate
  • +3 more
  • abiraterone acetate
  • +4 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Apr 26, 2017

Adenocarcinoma of the Prostate, Recurrent Prostate Cancer Trial in Portland (Sulforaphane, Laboratory biomarker analysis,

Completed
  • Adenocarcinoma of the Prostate
  • Recurrent Prostate Cancer
  • Portland, Oregon
    OHSU Knight Cancer Institute
Apr 26, 2017

Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage IV Prostate Cancer Trial in Rochester (tanespimycin, laboratory

Completed
  • Adenocarcinoma of the Prostate
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic
Mar 20, 2017

Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage IV Prostate Cancer Trial in San Francisco (ixabepilone,

Completed
  • Adenocarcinoma of the Prostate
  • +2 more
  • San Francisco, California
    UCSF Helen Diller Family Comprehensive Cancer Center
Feb 21, 2017

Prostate Cancer, Adenocarcinoma of the Prostate, Recurrent Prostate Cancer Trial in Orange (sunitinib malate, docetaxel,

Terminated
  • Prostate Cancer
  • +5 more
  • sunitinib malate
  • +2 more
  • Orange, California
    Chao Comprehensive Cancer Center
Dec 6, 2016

Recurrent Prostate Cancer Trial in Baltimore (Testosterone cypionate, Goserelin, Leuprolide)

Completed
  • Recurrent Prostate Cancer
  • Testosterone cypionate
  • +2 more
  • Baltimore, Maryland
    The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Oct 10, 2016

Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer, Stage IV Prostate Cancer Trial in Seattle (radiation, procedure,

Withdrawn
  • Hormone-resistant Prostate Cancer
  • +2 more
  • carbon-11 acetate
  • +3 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Aug 29, 2016

Recurrent Prostate Cancer, Stage I Prostate Cancer, Stage IIA Prostate Cancer Trial in Ann Arbor (cilengitide)

Completed
  • Recurrent Prostate Cancer
  • +4 more
  • Ann Arbor, Michigan
    University of Michigan University Hospital
Mar 28, 2016

Recurrent Prostate Cancer Trial in Chicago, Madison (pazopanib HCl, leuprolide acetate, goserelin acetate)

Completed
  • Recurrent Prostate Cancer
  • pazopanib hydrochloride
  • +2 more
  • Chicago, Illinois
  • +1 more
Jan 8, 2016

Prostate Cancer, Metastatic Prostate Cancer, Androgen-independent Prostate Cancer Trial in Sutton Surrey (onapristone,

Unknown status
  • Prostate Cancer
  • +3 more
  • Sutton Surrey, United Kingdom
    Inst of Cancer Research & Royal Marsden NHS Foundation Trust
Jun 22, 2015

Salvage Cryotherapy in Recurrent Prostate Cancer

Terminated
  • Recurrent Prostate Cancer
  • Cryoablation / Cryotherapy
  • Loma Linda, California
  • +16 more
May 26, 2015

Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer, Stage IV Prostate Cancer Trial in United States (saracatinib,

Terminated
  • Hormone-resistant Prostate Cancer
  • +2 more
  • Chicago, Illinois
  • +14 more
Mar 18, 2015

Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Cleveland (linsitinib,

Completed
  • Adenocarcinoma of the Prostate
  • +3 more
  • Cleveland, Ohio
  • +1 more
Mar 2, 2015

Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage IIB Prostate Cancer Trial in Sacramento (perifosine, laboratory

Terminated
  • Adenocarcinoma of the Prostate
  • +4 more
  • Sacramento, California
    UC Davis Cancer Center
Feb 9, 2015

Diarrhea, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Los Angeles (cabazitaxel, prednisone, octreotide

Terminated
  • Diarrhea
  • +7 more
  • Los Angeles, California
    USC/Norris Comprehensive Cancer Center
Nov 21, 2014

Recurrent Prostate Cancer, Stage I Prostate Cancer, Stage IIA Prostate Cancer Trial in Philadelphia (lapatinib ditosylate,

Completed
  • Recurrent Prostate Cancer
  • +4 more
  • lapatinib ditosylate
  • laboratory biomarker analysis
  • Philadelphia, Pennsylvania
    ECOG-ACRIN Cancer Research Group
Sep 19, 2014

Bone Metastases, Recurrent Prostate Cancer, Stage I Prostate Cancer Trial in Boston (procedure, radiation, other)

Completed
  • Bone Metastases
  • +6 more
  • magnetic resonance imaging
  • +5 more
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Jul 1, 2014

Adenocarcinoma of the Prostate, Hormone-refractory Prostate Cancer, Recurrent Prostate Cancer Trial in United States (eribulin

Completed
  • Adenocarcinoma of the Prostate
  • +3 more
  • eribulin mesylate
  • Scottsdale, Arizona
  • +146 more
May 21, 2014

Recurrent Prostate Cancer, Stage IV Prostate Cancer, Solid Tumor Trial in New York (tanespimycin, docetaxel)

Completed
  • Recurrent Prostate Cancer
  • +2 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jun 16, 2014

Recurrent Prostate Cancer, Stage IV Prostate Cancer Trial in Ann Arbor (vorinostat, laboratory biomarker analysis)

Completed
  • Recurrent Prostate Cancer
  • Stage IV Prostate Cancer
  • Ann Arbor, Michigan
    University of Michigan
Apr 25, 2014

Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in New Haven, Chicago (drug,

Completed
  • Adenocarcinoma of the Prostate
  • +3 more
  • New Haven, Connecticut
  • +1 more
Apr 21, 2014

Stage IV Prostate Cancer, Bone Metastases, Adenocarcinoma of the Prostate Trial run by the NCI (alendronate sodium,

Terminated
  • Stage IV Prostate Cancer
  • +3 more
  • Bethesda, Maryland
    Medicine Branch
Apr 21, 2014